The Oxford-based company is the first AI imaging company to join the organization focused on reducing the burden of cancer, leveraging its AI expertise to help accelerate drug discovery OXFORD, England, April 24, 2023 /PRNewswire/ — Brainomix has been announced as the newest member of…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.